We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$99.1B
AUM Growth
+$7.92B
Cap. Flow
+$3.27B
Cap. Flow %
3.3%
Top 10 Hldgs %
23.39%
Holding
4,186
New
432
Increased
2,037
Reduced
1,399
Closed
199

Sector Composition

Rank Sector Weight
1 Technology 14%
2 Financials 8.86%
3 Healthcare 8.09%
4 Industrials 6.83%
5 Consumer Discretionary 6.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAAS icon
3801
PUT
Pan American Silver
PAAS
$21.8B
$70K ﹤0.01%
+59,300
New +$1.93M
IID
3802
DELISTED
VOYA INTERNATIONAL HIGH DIVIDEND EQUITY INCOME FUND
IID
$70K ﹤0.01%
+12,620
New +$66.5K
PBT
3803
Permian Basin Royalty Trust
PBT
$1.56B
$69K ﹤0.01%
17,350
-1,200
-6% -$4.79K
WWR icon
3804
Westwater Resources
WWR
$77M
$69K ﹤0.01%
12,770
-40,230
-76% -$258K
HWM icon
3805
CALL
Howmet Aerospace
HWM
$113B
$67K ﹤0.01%
11,300
-600
-5% -$17.3K
BKCC
3806
DELISTED
BlackRock Capital Investment Corporation
BKCC
$66K ﹤0.01%
19,587
-5,011
-20% -$15.9K
UAVS icon
3807
AgEagle Aerial Systems
UAVS
$59.2M
$65K ﹤0.01%
10
-19
-66% -$178K
CBAT icon
3808
CBAK Energy Technology Ltd
CBAT
$69.1M
$64K ﹤0.01%
+12,500
New +$81.4K
MO icon
3809
CALL
Altria Group
MO
$108B
$64K ﹤0.01%
12,200
-14,200
-54% -$636K
NOVN
3810
DELISTED
Novan, Inc. Common Stock
NOVN
$64K ﹤0.01%
4,123
+53
+1% +$797
QTNT
3811
DELISTED
Quotient Limited Ordinary Shares
QTNT
$64K ﹤0.01%
435
-15
-3% -$2.96K
NGL icon
3812
NGL Energy Partners
NGL
$2.15B
$62K ﹤0.01%
30,504
-3,433
-10% -$8.8K
GTHX
3813
CALL
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$62K ﹤0.01%
+13,500
New +$314K
EOD
3814
Allspring Global Dividend Opportunity Fund
EOD
$286M
$61K ﹤0.01%
11,585
GERN icon
3815
Geron
GERN
$1.05B
$61K ﹤0.01%
38,700
MBRX icon
3816
Moleculin Biotech
MBRX
$3.17M
$61K ﹤0.01%
+40
New +$73.3K
AMD icon
3817
CALL
Advanced Micro Devices
AMD
$775B
$60K ﹤0.01%
+14,200
New +$1.22M
RMTI icon
3818
Rockwell Medical
RMTI
$27.9M
$60K ﹤0.01%
471
DWSN icon
3819
Dawson Geophysical
DWSN
$142M
$58K ﹤0.01%
23,550
PVLA
3820
Palvella Therapeutics
PVLA
$2.24B
$57K ﹤0.01%
275
BTG icon
3821
PUT
B2Gold
BTG
$6.7B
$56K ﹤0.01%
+51,000
New +$249K
EDIT icon
3822
CALL
Editas Medicine
EDIT
$455M
$56K ﹤0.01%
+30,200
New +$1.72M
FSM icon
3823
CALL
Fortuna Silver Mines
FSM
$3.19B
$56K ﹤0.01%
35,000
-46,100
-57% -$347K
AGRX
3824
DELISTED
Agile Therapeutics
AGRX
$56K ﹤0.01%
13
-1
-7% -$5.41K
FRX.WS
3825
DELISTED
Forest Road Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of C
FRX.WS
$55K ﹤0.01%
+20,399
New +$61.8K

Similar funds

Raymond James & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Raymond James & Associates held 4,186 positions worth $99.1B, up 8.7% from $91.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates deployed $3.27B of net new capital in Q1 2021, opening 432 new positions and adding to 2,037 existing holdings. Its largest new stake was BlackRock Technology and Private Equity Term Trust: 1,676,875 shares worth $34M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard High Dividend Yield ETF, an estimated $671M trimmed.

  • Raymond James & Associates's largest Q1 2021 buy was BlackRock Technology and Private Equity Term Trust: 1,676,875 shares worth $34M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2021, an estimated $1.36B increase.
  • Raymond James & Associates's biggest Q1 2021 reduction was Vanguard High Dividend Yield ETF, cutting an estimated $671M.
  • Raymond James & Associates fully exited Sensient Technologies in Q1 2021, selling an estimated $15.6M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $99.1B portfolio in Q1 2021.
  • Raymond James & Associates opened 432 new positions and closed 199 in Q1 2021.
  • Raymond James & Associates's portfolio value rose 8.7% quarter-over-quarter to $99.1B.

Based on Raymond James & Associates's 13F filing for Q1 2021, filed 14 May 2021.